60¢sixtycents

ImageneBio IncIMA

$6.00+0.31 (+5.45%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$67M
Micro-cap
-99%
2021 — today
10-Year Price
-99%
2021 — today
52-Week Range
$4.55$17.90
Current $6.00· 11%

ImageneBio Inc (IMA) is a biotechnology company with therapies currently undergoing human trials. The firm concentrates on creating innovative medical treatments for a variety of immune-related and inflammatory diseases. A key component of their pipeline is IMG-007, a non-depleting anti-OX40 monoclonal antibody, which is now in Phase 2b clinical studies targeting atopic dermatitis.

Valuation in context

P/E ratio
-1.3
N/A
Not meaningful — company is unprofitable
P/B ratio
0.5
Historically cheap
Historically cheap relative to the last 10 years
FCF Yield
-77.4%
Near historic low
Near historic low — last 10 years
Free · No credit card needed

Get alerted when IMA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.